World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

Login Register
World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

SJIF Impact Factor: 6.842

Abstract

METASTATIC BREAST CANCER TO THE THYROID GLAND: A CASE REPORT AND REVIEW OF THE LITERATURE

*Fatima-Zahra Kahouadji, Sihame Lkhoyaali, Saber Boutayeb, Ibrahim El Ghissassi, Hind M’rabti and Hassan Errihani

ABSTRACT

Breast cancer rarely metastasizes to the thyroid gland. We report a case history of a 40-year-old patient with inflammatory breast cancer treated with neoadjuvant chemotherapy at surgery, followed by adjuvant radiotherapy and hormonal therapy. After 4 years of diagnosis and treatment, she presented with a metastatic thyroid relapse revealed clinically by an anterior cervical swelling, biologically by thyroiditis unimproved by replacement therapy, histologically by thyroid biopsy and radiologically by pet scan. The evolution was favorable with a very good clinical and metabolic response after 6 months of 2nd-line chemotherapy.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR